September 26, 2025

Institutional Partnership: Heidelberg and Harvard Sign Memorandum of Understanding

Institutional Partnership: Heidelberg and Harvard Sign Memorandum of Understanding

State of Baden-Württemberg funds the intensifying of existing cooperative relations with ten million euros

On the basis of the cooperative relations that have developed over time, Heidelberg University and Harvard University are going to deepen and expand their cooperation. Prof. Dr Alan M. Garber, President of Harvard University, and Prof. Dr Frauke Melchior, Rector of Heidelberg University in Germany, have signed a Memorandum of Understanding to that effect. As an institutional internationalization project, the state of Baden-Württemberg is providing the sum of ten million euros to support this Heidelberg initiative. The funding is part of the state’s “Global Partnership in Science” activities.

The President of Harvard University, Prof. Dr Alan M. Garber, and the Rector of Heidelberg University, Prof. Dr Frauke Melchior, signed the Memorandum of Understanding on 28 August 2025 in Cambridge (USA). | Heidelberg University (Katja Simons)

Harvard University has for decades been the U.S. university with which Heidelberg University has kept up the most extensive relations of active cooperation. These numerous individual connections – for example, through the Heidelberg Center for American Studies, the Heidelberg Center for Ibero-American Studies, the South Asia Institute, the Heidelberg Institute of Global Health, the Institute for Molecular Systems Engineering and Advanced Materials and the Centre for Astronomy – will now be fitted into a clearly structured framework. At the same time, the Memorandum of Understanding forms the basis for further subject-related agreements that the schools, departments, and units of both universities will explore and advance. Special significance is attached to promoting first-rate research with joint projects, specifically in the life sciences, molecular engineering sciences, natural sciences and selected humanities. Young researchers are also to receive sustainable support through the expansion of exchange programs.

To prepare for the structural deepening of the partnership, Heidelberg University has conducted a comprehensive stocktaking of all existing cooperation agreements with Harvard and supplemented it with a university-wide survey of potential future projects. Feasible lines of cooperation are currently being strategically planned and conceptualized in several disciplines – including in the fields of Global Public Health / Medicine, Life Sciences, Astrophysics, Sinology / Asia Studies, Theology, History and American Studies, Environmental Physics / Sustainability Sciences and Molecular Engineering.

Additional measures to intensify cooperation activities include establishing a teaching hub in Heidelberg with digital and hybrid teaching formats, creating an incubator to generate third-party-funded projects and organizing an innovation hub for transfer activities. Using the state funding available for financing visiting scholars and researchers in Heidelberg, the university has made preparations for concrete cooperation at the local level by providing laboratory facilities and work places as well as accommodation in its guest houses. That is designed to attract early-career researchers along with established scientists and scholars.

The President of Harvard University and the Rector of Heidelberg University signed the Memorandum of Understanding on 28 August 2025 in Cambridge (USA).

Our latest News

discover more
China’s NMPA approves Promega’s MSI detection kit as a companion diagnostic for KEYTRUDA®

China’s NMPA approves Promega’s MSI detection kit as a companion diagnostic for KEYTRUDA®

The National Medical Products Administration (NMPA) in China has approved the OncoMate® Microsatellite Instability (MSI) Detection Kit as a Class III in vitro diagnostic device in China. It is intended as a companion diagnostic to identify patients with MSI-high (MSI-H) solid tumors for treatment with KEYTRUDA® (pembrolizumab), the anti-PD-1 therapy from Merck & Co., Inc., […]

aimed analytics GmbH highlighted in deutsche-startups.de

aimed analytics GmbH highlighted in deutsche-startups.de

5 neue Startups: ONOX, aimed analytics, Recarbox, FORMIC, showroom.fm Es ist wieder soweit – neue Startups stehen in den Startlöchern! Hier sind einige spannende junge Unternehmen, die man kennen sollte. Heute werfen wir einen Blick auf diese Neugründungen: ONOX, aimed analytics, Recarbox, FORMIC und showroom.fm. deutsche-startups.de stellt heute erneut eine Auswahl junger Startups vor, die […]

BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

BioMed X Launches First Research Project in Partnership with the Government of Barbados to Advance Therapy of Early Diabetic Kidney Disease

Bridgetown, Barbados, January 27, 2026 – BioMed X, a leading innovation hub for pharma, today announced the launch of its first research project in partnership with the Government of Barbados and with support from the European Union’s PharmaNext Programme. The new global call for research proposals, entitled “AI-Enabled Therapy of Early Diabetic Kidney Disease in Barbados,” addresses one of the most pressing and underexplored […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp